The Globe and Mail reports in its Wednesday, Nov. 29, edition that Scotia Capital analyst Jonathan Goldman rates CCL Industries "sector outperform" in new coverage. The Globe's David Leeder writes in the Eye On Equities column that Mr. Goldman set a share target of $72. Analysts on average target the shares at $73.89. Mr. Goldman says in a note: "With organic growth expected to reaccelerate, structural margin expansion opportunities, and conditions primed for large-scale M&A (and significant balance sheet flexibility), we see ample catalysts for the shares to break out of the six-year trading range. What you see is what you get. About 60 per cent of CCL's end-market exposure is defensive, including Home & Personal Care, Food & Beverage, and Healthcare. Organic growth has mostly tracked above GDP, supported by internal initiatives and secular trends. Scale and industry dynamics support stable margins around 20 per cent, and capex typically aligns with D&A. FCF conversion is stable within a narrow band around 45 per cent. ... Shares were a ten-bagger between 2012 and 2017, but have been range bound since as performance has tracked lower growth. ... We expect organic growth to reaccelerate in 2024."